Bionexus Gene Lab CORP 8-K Filing
Ticker: BGLC · Form: 8-K · Filed: Dec 30, 2025 · CIK: 1737523
| Field | Detail |
|---|---|
| Company | Bionexus Gene Lab CORP (BGLC) |
| Form Type | 8-K |
| Filed Date | Dec 30, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Bionexus Gene Lab CORP (ticker: BGLC) to the SEC on Dec 30, 2025.
How long is this filing?
Bionexus Gene Lab CORP's 8-K filing is 2 pages with approximately 572 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 572 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2025-12-30 13:30:52
Filing Documents
- bglc_8k.htm (8-K) — 42KB
- 0001477932-25-009240.txt ( ) — 157KB
- bglc-20251224.xsd (EX-101.SCH) — 5KB
- bglc-20251224_lab.xml (EX-101.LAB) — 15KB
- bglc-20251224_cal.xml (EX-101.CAL) — 1KB
- bglc-20251224_pre.xml (EX-101.PRE) — 9KB
- bglc-20251224_def.xml (EX-101.DEF) — 2KB
- bglc_8k_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders On December 24, 2025, BioNexus Gene Lab Corp. (the "Company") held its 2025 Annual Meeting of Stockholders (the "Annual Meeting"). The matters voted upon at the Annual Meeting and the final voting results were as follows: Proposal 1 — Election of Directors Each of the following nominees was elected to serve as a director of the Company to hold office until the Company's next annual meeting of stockholders or until his or her successor is duly elected and qualified. Nominee Votes For Votes Against Abstentions Su-Leng Tan Lee 972,902.8 4,485.5 300 Muhammad Azrul bin Abdul Hamid 972,902.8 4,485.5 300 Jook Yuen Low 971,641.8 4,485.5 1,561 Chee Keong Yap 972,902.8 4,485.5 300 Proposal 2 — Approval of the 2025 Equity Incentive Plan The Company's 2025 Equity Incentive Plan was approved. Votes For Votes Against Abstentions 966,759.8 10,628.5 300 Proposal 3 — Ratification of Independent Registered Public Accounting Firm The appointment of JP Centurion & Partners PLT as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified. Votes For Votes Against Abstentions 973,284.3 3,402.5 1,001.5 Proposal 4 — Approval of Adjournment Proposal The proposal to approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies was approved. Votes For Votes Against Abstentions 966,489.3 9,647.5 1,551.5 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BioNexus Gene Lab Corp. /s/ Su-Leng Tan Lee By: Su-Leng Tan Lee Chief Executive Officer Date: December 30, 2025 3